Fractures: Clinical Trials

2 trials for Fractures, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 terminated. 2 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 32Terminated 2
Phase 21Terminated 1

Follow Fractures: new trials by email Literature Review of Fractures trials Research Report on Fractures

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Ketamine Patient-Controlled Analgesia for Acute Pain
Ketamine, Hydromorphone - Acute Pain, Multiple Trauma
Phase 3TerminatedUniversity of Cincinnati202014-04-012017-09-21
A Phase 2/3 Multicenter, Controlled Trial Of rhBMP-2/CPM In Tibial Fractures
rhBMP-2/CPM - Fractures
Phase 2 / Phase 3TerminatedWyeth is now a wholly owned subsidiary of Pfizer3672006-11-012013-02-28

Narrower conditions

Fractures, Bone (2)  ·  Acute Pain (1)  ·  Multiple Trauma (1)  ·  Pain (1)  ·  Wounds and Injuries (1)

Broader conditions

Neurologic Manifestations (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Signs and Symptoms (1)  ·  Wounds and Injuries (1)

Interventions

Hydromorphone (1)  ·  Ketamine (1)

Sponsors

University of Cincinnati (1)  ·  Wyeth is now a wholly owned subsidiary of Pfizer (1)

Countries

United States (2)  ·  Argentina (1)  ·  Australia (1)  ·  Brazil (1)  ·  Canada (1)  ·  Finland (1)  ·  France (1)  ·  Germany (1)  ·  India (1)  ·  Latvia (1)  ·  Mexico (1)  ·  Poland (1)  ·  Romania (1)  ·  Serbia (1)  ·  Slovenia (1)

Top investigators

Eric W Mueller, Pharm.D. (1)  ·  Sheila C Takieddine, Pharm.D. (1)

Results publications

PMID 29605036